Dextrans as Permeation Markers and Carriers for Oral Transmucosal Drug Delivery

被引:0
|
作者
Berka, Pavel [1 ,2 ]
Berka, Karel [3 ]
Dolezal, Pavel [1 ]
机构
[1] Univ Karlova Praze, Farmaceut Fak Hradci Kralove, Katedra Farmaceut Technol, Ak Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
[2] InStar Technol As, Mrstikova 399-2a, Liberec 46007, Czech Republic
[3] Univ Palackeho Olomouci, Prirodovedecka Fak, Katedra Fyzikalni Chem, RCPTM, 17 Listopadu 12, Olomouc 77146, Czech Republic
来源
CHEMICKE LISTY | 2020年 / 114卷 / 08期
关键词
dextrans; sublingual administration; gyration radius; drug carriers; IN-VITRO; CARBOXYMETHYL-DEXTRAN; PERMEABILITY; ABSORPTION; COMPLEXATION; POLYMERS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dextrans are studied as markers of oral transmucosal permeability and as possible drug carriers. The therapeutic use of dextrans is primarily limited to the intravenous route of administration. This work focuses on extending the knowledge of dextran permeation by the sublingual route. First, it is documented that non-keratinized sublingual membranes are very sensitive to heat treatment and storage conditions (more than skin membranes). Slow freezing disrupts them seriously, leading to disproportionately high permeability values, even for dextrans with a molecular weight higher than 20 kDa, which, however, may well serve as permeation markers. The dextran gyration radius reflects in vitro oral transmucosal permeability characteristics more appropriately than the pertinent molecular weight values. Macromolecular systems with a gyration radius analogous to 4 kDa dextran, possibly coupled with low molecular weight drugs, have sufficient potential for sublingual systemic drug delivery.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [1] Advances in oral transmucosal drug delivery
    Patel, Viralkumar F.
    Liu, Fang
    Brown, Marc B.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2011, 153 (02) : 106 - 116
  • [2] Biodegradable nanostructures as carriers for transmucosal drug delivery.
    Alonso, MJ
    Prego, C
    García, M
    Sánchez, AV
    Torres, D
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U469 - U469
  • [3] Oral transmucosal drug delivery for pediatric use
    Lam, Jenny K. W.
    Xu, Yingying
    Worsley, Alan
    Wong, Ian C. K.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2014, 73 : 50 - 62
  • [4] Oral transmucosal drug delivery for pediatric use
    [J]. Lam, J.K.W. (jkwlam@hku.hk), 1600, Elsevier B.V., Netherlands (73):
  • [5] Oral transmucosal drug delivery for pediatric use
    Lam, Jenny K.W.
    Xu, Yingying
    Worsley, Alan
    Wong, Ian C.K.
    [J]. Advanced Drug Delivery Reviews, 2014, 73 : 50 - 62
  • [6] Mucoadhesive Polymers for Oral Transmucosal Drug Delivery: A Review
    Bagan, Jose'
    Paderni, Carlo
    Termine, Nicoletta
    Campisi, Giuseppina
    Lo Russo, Lucio
    Compilato, Domenico
    Di Fede, Olga
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (34) : 5497 - 5514
  • [7] Permeation enhancers in the transmucosal delivery of macromolecules
    Sharma, S.
    Kulkarni, J.
    Pawar, A. P.
    [J]. PHARMAZIE, 2006, 61 (06): : 495 - 504
  • [8] Oral transmucosal drug delivery - Current status and future prospects
    Sattar, Mohammed
    Sayed, Ossama M.
    Lane, Majella E.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 471 (1-2) : 498 - 506
  • [9] Mucoadhesive carriers for oral drug delivery
    Kumar, Raj
    Islam, Tamanna
    Nurunnabi, Md
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 351 : 504 - 559
  • [10] Mucoadhesive carriers for oral drug delivery
    Kumar, Raj
    Islam, Tamanna
    Nurunnabi, Md
    [J]. Journal of Controlled Release, 2022, 351 : 504 - 559